Cost-Effectiveness Analysis of Nirsevimab Prophylaxis for Prevention of Respiratory Syncytial VirusDisease Among Infants in South Korea

Author

Han HJ, Jang S, Ryu D, Bae EJ, Soudani S, Suh HS

Journal

The 2024 International Society for Pharmacoeconomics and Outcomes Research EU

Remarks

Barcelona, Spain. Nov. 2024